Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA approves Ligand's Targretin Capsules for treatment of CTCL

Dec. 30, 1999

Warner-Lambert reports R&D progress in the area of kinase inhibitors

Dec. 30, 1999

Antiangiogenic fumagillin analogues in the pipeline at BioChem Pharma

Dec. 29, 1999

Mitsui presents differentiation-inducing agents

Dec. 29, 1999

BIM-46068: a pseudopeptide FTase inhibitor with promise for cancer Rx

Dec. 29, 1999

Millennium validates prostate cancer gene target as part of Lilly collaboration

Dec. 29, 1999

MGH team identifies TSP-2 as a novel endogenous antiangiogenic factor

Dec. 29, 1999

Sugen succeeds in designing a potent, orally active PK inhibitor with antitumor activity

Dec. 28, 1999

FDA clears Taxotere for marketing in NSCLC

Dec. 28, 1999

SuperGen, Abbott reach distribution agreement for anticancer drugs

Dec. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...